Study shows lasting benefits of weight loss and diabetes remission for the heart and kidneys

Researchers in the School of Population Health at RCSI University of Medicine and Health Sciences have provided new evidence of the health benefits of weight loss efforts that lead to diabetes remission for type 2 diabetes patients.

First Opinion readers on clinical trials in Africa, compounded semaglutide, depressed mice, and more

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers,

September 21, 2024

GSK details Blenrep’s PhIII combo win as it hopes to stage a turnaround in multiple myeloma

GSK’s Blenrep in combination with two other medicines cut the risk of disease progression or death by 59% compared to a standard combination for multiple

February 6, 2024

Immunic to Participate in Industry, Scientific and Investor Conferences in November – Biotech Investments

Issuer: Immunic AG / Key word(s): Conference 29.10.2024 / 11:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Participate

October 30, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.